WUHAN, China

James Tien

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Xwpharma Ltd.. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Tien. Retrieved from https://idiyas.com/inventor/james-tien-i6n814kz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by James Tien in Pharmaceutical Compositions

Introduction

James Tien is a notable inventor based in Wuhan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of modified release compositions. With a total of 2 patents, Tien's work focuses on enhancing the delivery and effectiveness of pharmaceutical compounds.

Latest Patents

James Tien's latest patents include innovative pharmaceutical granulations that feature a functional coating surrounding a core containing 4-((L-valyl)oxy)butanoic acid. These compositions are designed to provide either immediate release or modified release of the active ingredient. The pharmaceutical granulations can be utilized in oral pharmaceutical compositions, showcasing Tien's commitment to improving drug delivery systems.

Career Highlights

Tien is currently associated with Xwpharma Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating formulations that enhance the therapeutic efficacy of medications.

Collaborations

James Tien collaborates with esteemed colleagues such as Sami Karaborni and Daniel M Canafax. Their combined expertise contributes to the innovative projects at Xwpharma Ltd.

Conclusion

James Tien's contributions to pharmaceutical innovations reflect his dedication to improving healthcare through advanced drug formulations. His patents and ongoing research are paving the way for more effective treatments in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…